Pet Diabetes Care Devices Market Size, Share, and Trends 2024 to 2033

Pet Diabetes Care Devices Market Size and Manufacturers

The global pet diabetes care devices market size was valued at USD 2.48 billion in 2023 and is anticipated to reach around USD 4.91 billion by 2033, growing at a CAGR of 7.05% from 2024 to 2033.

Access our Healthcare Data Intelligence Tool with 10000+ Database, Visit: Towards Healthcare

Key Takeaways

• North America held the largest market share of 37% in 2023.
• The Asia-Pacific region is observed to witness the fastest rate of expansion during the forecast period.
• By device, the insulin delivery devices segment has contributed more than 93% of the market share in 2023.
• By animal, the dogs segment led the market with the major market share of 55% in 2023.
• By end-users, the veterinary hospitals segment has recorded more than 42% of the market share in 2023.

Pet Diabetes Care Devices Market Size in the U.S. 2024 To 2033

The U.S. pet diabetes care devices market size reached USD 640 million in 2023 and is predicted to be worth around USD 1,270 million by 2033, poised to grow at a CAGR of 7.10% from 2024 to 2033.

North America held the dominating the largest pet diabetes care devices market share of 37% in 2023. The United States, being the largest contributor of the market in the region is observed to sustain the position throughout the forecast period. The region’s dominance and rapid growth is due to the increasing number of pet owners, awareness regarding pet health, and government initiatives. The region has comparatively high and advanced veterinary sectors, such as clinics and hospitals for pet care, specialized professions, and doctors.

The Asia-Pacific region holds the title of the fastest-growing region in the pet diabetes care devices market for the forecast period. The rapid surge in business activities in pet care sector acts as a major driver for the market. Various startups for pet care have been established in the region, including an extensive array of products and services, encompassing nutrition, healthcare, and training, to establish an ultimate pet care ecosystem in the country.

Major manufacturers and distributors of pet diabetes care devices are expanding their presence in the Asia Pacific region, either through direct sales channels or partnerships with local distributors. This increased market penetration enhances the availability and accessibility of diabetes care devices, further driving market growth. As pet owners in Asia Pacific become more affluent, they are willing to invest in advanced healthcare services and products for their pets. This includes the purchase of diabetes care devices that offer convenience, accuracy, and ease of use in managing their pets' diabetes.

Pet Diabetes Care Devices Market Overview

Diabetes is relatively common in dogs and cats. Pets with diabetes require extra care and lifelong treatment, including special diets, good fitness regimens, monitoring devices, regular insulin injections, and proper veterinarian checkups. The treatment varies from one pet to another. Also, it is essential to check pets' blood and urine sugar levels regularly. Apart from veterinarian visits, regular examinations and testing using home monitoring devices are best for checking blood and urine glucose levels. The advanced devices detect pet healthcare by monitoring health status and managing health issues in order to prevent severe complications.

The pet diabetes care devices market offers essential tools and devices for managing health conditions. These devices come in different shapes and sizes and include glucose monitoring systems, insulin pens and glucose meters. Veterinary clinics play a crucial role in promoting these devices and uplifting the global market during the forecast period.

Healthcare professionals and caretakers in veterinary clinics promote the use of pet diabetes care devices to better care for pets. These devices help pet owners diagnose pet conditions, and veterinarians provide guidance on how to use them effectively. Additionally, they can advise pet owners on providing better nutrition and monitoring their pet's blood glucose. The growing awareness of pet health and well-being has created an increased need for cutting-edge diabetic care equipment to monitor and manage the health and quality of life of companion animals with diabetes.

Growth Factors

• The increased spread of pet diseases globally due to genetic reasons, poor nutrition, diet, and bad lifestyle influenced the market for pet diabetes care devices.
• People enjoy adopting pets more and treat them like their companions, so they are also concerned about managing the health of pets. For instance, the United States is mainly attracted to pets, and the region is rapidly growing due to an increase in the number of pet owners.
• Growing technological advancements in pet diabetes care devices significantly increase the market size. The introduction of insulin pens, continuous glucose monitoring, and insulin pumps uplift the pet diabetes care devices market.
• Agreements and partnerships between small and mid-sized players in the market are opportunistic options for inorganic growth. They contribute their efforts to market growth by providing innovative solutions and producing high-quality products.
• Governments globally are taking steps, initiative plans, and policies to promote and grow awareness towards pet diabetes and other diseases, which has a positive impact on the market. 

Pet Diabetes Care Devices Market Scope

Pet Diabetes Care Devices Market Dynamics

Drivers

Rising pet population

The pet population is rapidly increasing worldwide, which is leading to a higher demand for diabetes care devices for pets. This factor is observed to act as a major driver for the pet diabetes care devices market.

• According to a report by the American Pet Products Association, the number of pets is growing by nearly 5% each year in the United States.

As the pet population grows, so does the prevalence of diabetes among companion animals. Factors such as aging pets, obesity, genetic predisposition, and changes in lifestyle contribute to the rising incidence of diabetes in pets, necessitating the use of specialized diabetes care devices for management and treatment. Pet owners are increasingly prioritizing the health and wellbeing of their pets, leading to greater investments in preventive and therapeutic healthcare measures. As diabetes can significantly impact the quality of life and longevity of pets, pet owners are more inclined to invest in diabetes care devices to ensure optimal management of the condition.

Promotion of diabetes care devices by veterinarians

Healthcare professionals and animal caretakers at veterinary clinics are advocating for the use of pet diabetes care devices to improve the care of pets. These devices allow for easy monitoring of blood glucose levels in pets without causing any stress or requiring significant effort. Additionally, the use of diabetes devices can help pet owners avoid the need for frequent visits to hospitals and clinics.

Restraint

Lack of awareness regarding diabetes care devices for pets

Consumers, businesses, and policymakers may impede market growth by not fully appreciating the benefits and potential of pet diabetes care devices. Thus, the factors acts as a major restraint for the pet diabetes care devices market. Pet owners may not realize the availability of specialized diabetes care devices for pets, such as glucose monitoring systems, insulin pumps, and insulin pens. Without awareness of these treatment options, pet owners may not seek appropriate care for their diabetic pets or may rely solely on traditional treatment methods. There may be a stigma associated with pet diabetes, leading to reluctance among pet owners to acknowledge or address their pet's condition. This stigma can contribute to a lack of awareness and understanding of diabetes care devices for pets, further hindering market growth.

Opportunity

Advanced technologies for measuring blood glucose levels in pets

Traditionally, veterinarians have used a technique called glucose curves to measure blood sugar levels in pets. This method involves taking blood samples over a period of more than 12 hours and plotting the findings manually. However, this method is not very accurate in providing typical glucose levels due to situations that cause anxiety in pets, such as going to the vet, which can skew blood sugar levels. Additionally, the process is labour-intensive.

The small medical sensors known as continuous glucose monitors (CGMs) were developed to monitor blood glucose levels in humans with diabetes. Now, veterinarians are using these devices to monitor diabetes in pets as well. CGMs are less stressful for pets and less expensive than traditional monitoring methods. This technology also helps regulate diabetes in pets with proper medications. Thereby, the factor is observed to act as an opportunity for the expansion of the pet diabetes care devices market.

Device Insights

The pet diabetes care devices market is classified into glucose monitoring devices and insulin delivery devices. Out of these two the insulin delivery devices segment dominated the global market. With the increasing incidence of diabetes mellitus in pets, there is a rising demand for effective management solutions. Insulin delivery devices play a crucial role in administering insulin therapy, which is the primary treatment for diabetic pets.

Insulin delivery devices are designed to be user-friendly, allowing pet owners to administer insulin injections safely and effectively at home. This ease of use is essential for ensuring compliance with treatment regimens and maintaining optimal blood glucose levels in diabetic pets.

Animal Insights

The dogs segment dominated the pet diabetes care devices market with the largest share in 2023. Diagnosing diabetes in dogs can be relatively straightforward compared to other pets, as dogs often exhibit classic symptoms such as increased thirst, frequent urination, weight loss, and lethargy. Veterinary professionals routinely screen dogs for diabetes during wellness exams, leading to earlier diagnosis and intervention. Dogs are valued members of many households and are often considered part of the family. Pet owners are highly motivated to provide the best possible care for their canine companions, including investing in advanced medical technologies and treatments to manage chronic conditions like diabetes.

End-user Insights

The veterinary hospitals segment led the pet diabetes care devices market in 2023, the segment is observed to sustain the dominance throughout the forecast period. Veterinary hospitals are equipped with trained veterinarians and staff who specialize in diagnosing and treating pet diseases, including diabetes. They have the expertise to properly manage diabetes in pets and recommend appropriate treatment options, including the use of diabetes care devices. Veterinary hospitals have access to a wide range of advanced treatment options for managing diabetes in pets, including insulin therapy, dietary management, and exercise programs. They may also offer alternative therapies such as continuous glucose monitoring (CGM) systems and insulin pumps.

The home care settings segment is observed to witness a significant rate of growth in the pet diabetes care devices market during the forecast period. Home care settings enable pet owners to monitor their pet's blood glucose levels regularly, facilitating early detection of fluctuations and prompt intervention as needed. This continuous monitoring helps in maintaining tight glycemic control and preventing complications associated with diabetes. Home care settings can be more cost-effective for pet owners compared to frequent visits to veterinary clinics for diabetes management. While there may be initial investments in diabetes care devices and supplies, the long-term savings from reduced veterinary expenses can be significant.

Recent Developments

• In November 2023, Boehringer Ingelheim got approval for SENVELGO® in Europe. This is the first oral liquid medication available for diabetic cats, and it represents a significant advancement in treating feline diabetes in Europe. SENVELGO® can be given to cats once a day, either mixed with a small amount of food or directly administered into their mouth.
• In May 2023, UBI introduced the Petrackr, a diabetes monitoring device for pets. The product consists of a device and single-use test strips for collecting a small drop of blood sample and a hand-held monitor that can supervise multiple profiles of pets. The device accurately tracks, monitors, and displays the blood glucose levels of pets. The product has distribution partnerships in the United States and Canada.
• In Feb 2023, ALRT, a Singapore-based medical device company, launched GluCurve Pet CGM. It is a continuous monitoring device for diabetic cats and dogs produced in collaboration with Covetrus. It is designed to make diabetes management more effortless.

Pet Diabetes Care Devices Market Companies

• Merck animal health
• Becton
• Fitbark
• TaiDoc
• Dickinson
• Allison Medical
• Henry Schein
• Zoetis
• Ulticare
• Boehringer Ingelheim Vetmedica Inc.
• IDEXX Laboratories
• Johnson & Johnson Services, Inc
• Novo Nordisk
• Eli Lilly and Company
• Vetoquinol S.A. 

Segments Covered in the Report

By Device

• Glucose Monitoring Devices
• Insulin Delivery Devices
• Insulin Delivery Pen
• Insulin Delivery Syringes

By Animal

• Dogs
• Cats
• Horses

By End-use

• Veterinary Clinics
• Home Care Settings
• Veterinary Hospitals

By Geography

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa